For now, at least two lawmakers Tommy Tuberville (R-Ala.) and Diana Harshbarger (R-Tenn.) have issued letters asking the FDA to limit enforcement action against certain peptides, including BPC-157
Feel as if your health care system neglects you
Thyroid imbalances can worsen fatigue and joint stiffness in psoriatic arthritis
Any claim that one outperforms the other is inference across separate trials with different species, models, and endpoints not a measured result
Spinal Cord Injury BPC 157 has shown great promise in enhancing recovery processes following spinal cord injuries
But after burning through some $50 million developing the drug, Metabolic Pharmaceuticals Pty Ltd, which owns the patent, has continued to spruik its so-called body-enhancing benefits